Australia's Firebrick Pharma hits over 1-week high on Malaysia patent grant

Firebrick Pharma

25/05/2022 06:05

** Shares of pharmaceutical co  FRE.AX  jump as much as 5.2%
to A$0.405, their highest since May 16 
    ** Co says its patent covering Nasodine Nasal Spray as a
treatment and preventative for common cold has now been granted
in Malaysia  urn:newsml:reuters.com:*:nASX7FqNl6
    ** Shares gain for a third straight session 
    ** As of last close, stock down 27.4% since its ASX listing
on Jan. 28

 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))